Physician

Brian Anthony Dicarlo, MD

According to 2025 Medicare claims, Brian Dicarlo, MD (NPI: 1982728796) practices medical oncology in the San Luis Obispo-Paso Robles, CA market, with the plurality of this provider's patient population coming from San Luis Obispo, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 93401-8054.

Dicarlo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 821 traditional Medicare patients, billed 432,751 HCPCS/CPT codes, and received $10,167,905 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,113 prescription claims across 357 beneficiaries totaling $8,204,767 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 59 claims. Open Payments data shows 10 records totaling $421. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $157,153 to $10,167,905. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,492,518 to $8,204,767. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,801 to $2,280.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.1M$10M2015 Medicare payment: $157,153 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $166,580 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $174,998 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $170,533 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,744,049 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,193,124 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,338,004 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,670,965 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,054,509 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $10,167,905 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153961,760$157,153
20164591,861$166,580
20175131,986$174,998
20185062,034$170,533
2019555187,570$3,744,049
2020609371,077$6,193,124
2021637342,781$6,338,004
2022682345,922$6,670,965
2023787431,175$9,054,509
2024821432,751$10,167,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.1M$8.2M2015 Drug cost: $2,492,518 (USD; Tot_Drug_Cst)2016 Drug cost: $2,970,134 (USD; Tot_Drug_Cst)2017 Drug cost: $2,535,923 (USD; Tot_Drug_Cst)2018 Drug cost: $3,490,128 (USD; Tot_Drug_Cst)2019 Drug cost: $4,269,816 (USD; Tot_Drug_Cst)2020 Drug cost: $3,641,504 (USD; Tot_Drug_Cst)2021 Drug cost: $4,208,550 (USD; Tot_Drug_Cst)2022 Drug cost: $5,489,129 (USD; Tot_Drug_Cst)2023 Drug cost: $6,871,439 (USD; Tot_Drug_Cst)2024 Drug cost: $8,204,767 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152211,496$2,492,518
20162371,394$2,970,134
20172401,102$2,535,923
20182631,331$3,490,128
20192931,514$4,269,816
20202541,425$3,641,504
20212761,452$4,208,550
20222951,785$5,489,129
20233561,984$6,871,439
20243572,113$8,204,767

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$29K$57K2015 Medicare payment: $54,592 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $38,737 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $23,197 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,959 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $14,865 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $17,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $10,526 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $57,114 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $22,429 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,534 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201512126$54,592
201629135$38,737
2017N/R101$23,197
2018N/R27$3,959
201941150$14,865
2020N/R217$17,988
2021N/R133$10,526
2022N/R157$57,114
2023N/R74$22,429
2024N/R59$2,534

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more304790$143
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5741,355$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more200249$68
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's339720$13
J7050Infusion, normal saline solution, 250 cc1811,269$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LenalidomideLenalidomide451,260$841,644
JakafiRuxolitinib Phosphate25750$719,824
RevlimidLenalidomide32896$664,855
TagrissoOsimertinib Mesylate34960$547,566
CabometyxCabozantinib S-Malate17510$477,927

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R20$1,402
J8521Capecitabine, oral, 500 mgNN/R21$882
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R18$251

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$421Genmab U.S., Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian Anthony Dicarlo, MD?

Tedicare shows public-source Medicare data for Brian Anthony Dicarlo, MD (NPI 1982728796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Anthony Dicarlo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Anthony Dicarlo, MD?

Brian Anthony Dicarlo, MD is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Brian Anthony Dicarlo, MD have Open Payments data?

Brian Anthony Dicarlo, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.